CGON EBITDA Growth

Cg Oncology Inc · EBITDA Growth

CGON logo

CGON EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-73.15%
CGON TTM EBITDA YoY % (-74.09% → -73.15%)
High-resolution chart · PNG

CGON ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cg Oncology Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-73.1459%
-74.8571%
-81.2965%
-108.6423%
-100.7598%
-87.0258%
-82.784%
-74.0865%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.